Carregant...
New Frontiers for the Cytoskeletal Protein LASP1
In the recent two decades, LIM and SH3 protein 1 (LASP1) has been developed from a simple actin-binding structural protein to a tumor biomarker and subsequently to a complex, nuclear transcriptional regulator. Starting with a brief historical perspective, this review will mainly compare and contrast...
Guardat en:
| Publicat a: | Front Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6160563/ https://ncbi.nlm.nih.gov/pubmed/30298118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00391 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|